WA
IMNM icon

Wealth Architects’s Immunome IMNM Stock Holding History

Wealth Architects’s Portfolio IMNM Stock Details IMNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-11,110
Closed -$92.8K – 202
2023
Q3 		$92.8K Hold
11,110
– – 0.02% 185
2023
Q2 		$87.9K Hold
11,110
– – 0.01% 189
2023
Q1 		$55.4K Hold
11,110
– – 0.01% 186
2022
Q4 		$24.6K Hold
11,110
– – ﹤0.01% 178
2022
Q3 		$49K Hold
11,110
– – 0.01% 171
2022
Q2 		$36K Hold
11,110
– – 0.01% 180
2022
Q1 		$63K Hold
11,110
– – 0.01% 203
2021
Q4 		$144K Hold
11,110
– – 0.03% 194
2021
Q3 		$271K Sell
11,110
-91
-0.8% -$1.59K 0.05% 146
2021
Q2 		$194K Buy
+11,201
New +$247K 0.04% 179

Other funds holding IMNM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wealth Architects's IMNM Position: Q4 2023 in Review

Wealth Architects sold out of Immunome (IMNM) in Q4 2023, closing a stake of 11,110 shares — an estimated $92.8K sold.

Wealth Architects first reported a position in IMNM in Q2 2021 and held it in 10 quarters. The position peaked at $271K in Q3 2021. 57 funds tracked by Wall St. Rank hold IMNM as of Q4 2023.

  • Wealth Architects reported no remaining Immunome position as of Q4 2023 after selling out during the quarter.
  • Wealth Architects sold 11,110 Immunome shares in Q4 2023, an estimated $92.8K.
  • Wealth Architects first reported a position in Immunome in Q2 2021 and held it in 10 quarters.
  • Wealth Architects's Immunome position peaked at $271K in Q3 2021.
  • 57 funds tracked by Wall St. Rank held Immunome as of Q4 2023.

Based on Wealth Architects's 13F filing for Q4 2023, filed 14 Feb 2024.